Cancer of Pancreas

Oncology
2
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
2
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
2100%
+ 2 programs with unclassified modality

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
1 program
1
BemcentinibPhase 1/2Small Molecule1 trial
Active Trials
NCT03649321Terminated9Est. Jun 2022
Boehringer Ingelheim
Boehringer IngelheimINGELHEIM, Germany
1 program
1
NintedanibPhase 1/2Small Molecule1 trial
Active Trials
NCT02902484Terminated14Est. Oct 2021
AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
Pre-operative stereotactic ablative body radiotherapyN/A1 trial
Active Trials
NCT04128332Unknown10Est. Dec 2022
Varian Medical Systems
1 program
Ring gantry kV-CBCT combined with linear acceleratorN/A1 trial
Active Trials
NCT04008537CompletedEst. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GenomicsBemcentinib
Boehringer IngelheimNintedanib
AstraZenecaPre-operative stereotactic ablative body radiotherapy
Varian Medical SystemsRing gantry kV-CBCT combined with linear accelerator

Clinical Trials (4)

Total enrollment: 33 patients across 4 trials

NCT03649321GenomicsBemcentinib

Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer

Start: Jan 2019Est. completion: Jun 20229 patients
Phase 1/2Terminated
NCT02902484Boehringer IngelheimNintedanib

Study of Nintedanib and Chemotherapy for Advanced Pancreatic Cancer

Start: Sep 2017Est. completion: Oct 202114 patients
Phase 1/2Terminated
NCT04128332AstraZenecaPre-operative stereotactic ablative body radiotherapy

Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer

Start: Oct 2020Est. completion: Dec 202210 patients
N/AUnknown
NCT04008537Varian Medical SystemsRing gantry kV-CBCT combined with linear accelerator

Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device

Start: Sep 2019Est. completion: Mar 2022
N/ACompleted

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
6m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
6m ago

Office Administrator

SystImmune
7m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
17m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
21m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
21m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)